Optique Franklin: Tennessee Optometrist Warns of Risks from Online Eye Exams GlobeNewswire August 11, 2025 Franklin, TN, Aug. 11, 2025 (GLOBE NEWSWIRE) — Doctors at Optique Franklin, optometrists in Franklin TN who offer personalized, high-quality vision care in an inviting, boutique-style setting, are warning of the potential dangers of relying on online eye exams after […]

SOLOWIN Expands Virtual Asset Services with Key License and Reports Significant Transactional Volume Growth GlobeNewswire August 11, 2025 HONG KONG, Aug. 11, 2025 (GLOBE NEWSWIRE) — SOLOWIN HOLDINGS (NASDAQ: SWIN) (“Solowin” or the “Company”), a leading financial services firm providing comprehensive solutions across traditional and digital assets, today announced that its wholly-owned subsidiary Solomon JFZ

ProPhase Labs Inc. to Present Second Quarter 2025 Financial Results on August 13, 2025 GlobeNewswire August 11, 2025 UNIONDALE, NY, Aug. 11, 2025 (GLOBE NEWSWIRE) — ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”), a next generation biotech, genomics and consumer products company, announced today that they will be presenting second quarter 2025 financial

Dynacor Reports Q2-2025 Results and Advances International Expansion Plan GlobeNewswire August 11, 2025 MONTREAL, Aug. 11, 2025 (GLOBE NEWSWIRE) — Dynacor Group Inc. (TSX: DNG) (“Dynacor” or the “Corporation”) today announced its unaudited financial and operational results1 for the second quarter ended June 30, 2025, and achievement of key milestones for its 2030 international expansion

Enphase Energy Continues Global Rollout of IQ Battery 5P with FlexPhase in Australia GlobeNewswire August 11, 2025 FREMONT, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced the launch of the IQ(R) Battery 5P(TM)

ArriVent BioPharma Reports Second Quarter 2025 Financial Results GlobeNewswire August 11, 2025 Positive interim Phase 1b update underscores firmonertinib's potential in EGFR PACC mutant NSCLC; global pivotal Phase 3 ALPACCA study expected to enroll first patient in 2H 2025 Dosed the first patient in the Phase 1 Study for ARR-217 (MRG007), a CDH17 targeted ADC,

4DMT Reports Second Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones GlobeNewswire August 11, 2025 4D-150 Phase 3 program in wet AMD advancing ahead of plan, with expected 4FRONT-1 data readout accelerated to H1 2027 from H2 2027 and 4FRONT-2 initiated ahead of schedule Presented positive 60-week results from 4D-150 SPECTRA clinical trial

Gabelli Funds to Host 31st Annual Aerospace & Defense Symposium at The Harvard Club, New York City Thursday, September 4, 2025 GlobeNewswire August 11, 2025 GREENWICH, Conn., Aug. 11, 2025 (GLOBE NEWSWIRE) — Gabelli Funds, LLC, is hosting our annual Aerospace & Defense Symposium at The Harvard Club in New York City on September 4th.

vTv Therapeutics Announces USPTO Allowance of Patent Covering Cadisegliatin GlobeNewswire August 11, 2025 HIGH POINT, N.C., Aug. 11, 2025 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company focused on the development of cadisegliatin, a potential first-in-class oral adjunctive therapy to insulin being investigated for the treatment of type 1 diabetes (T1D),

SharpLink's ETH Holdings Expected to Exceed $3 Billion Following $400 Million Registered Direct Offering with Institutional Investors GlobeNewswire August 11, 2025 MINNEAPOLIS, MN, Aug. 11, 2025 (GLOBE NEWSWIRE) — SharpLink Gaming, Inc. (Nasdaq: SBET) (“SharpLink” or the “Company”) today announced that it has entered into securities purchase agreements for an aggregate of $400 million with